ArticleCancer gene therapy2018

Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.

Biao Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.